🔴 A #VHIO-led study led by Laura Soucek and Fabio Giuntini shows that combining the MYC inhibitor #Omomyc (by VHIO & @icreacommunity.bsky.social's #Peptomyc) the with DNA-repair–targeted therapies boosts anti-tumor activity in preclinical triple-negative #BreastCancer.

➡️ linke.to/OmomycVHIO

🧬 Recently published in @jamaoncology.com: a consensus review led by César Serrano (#VHIO) outlines expert guidelines for the rational use of next-generation sequencing in diagnosing and treating sarcomas.

➡️ https://linke.to/SerranoJAMAVHIO

#SarcomaVHIO

💙 Thank you, Paseíco de la Mama, for your solidarity‼️
The donation from this edition will support #PORTRAIT_TNBC at #VHIO, led by Mafalda Oliveira, to advance research into personalised treatments for triple-negative #BreastCancer.
➡️ https://linke.to/PaseicoMama26VHIO_Eng
#MamaVHIO

🗞️ Published today at Cancer Discovery, an international study led by Rodrigo Toledo at #VHIO describes that oxygen-starved cancer cells develop similar survival strategies as the Sherpa population of the Himalayan region. 

👉 https://linke.to/SherpaRToledoVHIO

🗞️ Published in @cp-cellrepmed.bsky.social: A VHIO-led study reveals that the #RAD51 biomarker could complement next-generation sequencing to personalize #prostatecancer treatment.

➡️ linke.to/RAD51VHIO

🗞️ Published in Clinical Cancer Research, results of a #VHIO-led study underscore the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early #BreastCancer. 

🎯 Discover more here ➡️ https://linke.to/RAD51CCRVHIO

🔬 Large-scale cancer genomics can identify biomarkers of treatment non-response, helping spare patients ineffective therapies.

New #VHIO–Hartwig Medical Foundation study in @myesmo.bsky.social, first-authored by Joseph Usset and led by @franmj88.bsky.social.

➡️ https://linke.to/ESMORWFMartinez

🗞️ Recent findings in "The Lancet Oncology"‼️ #SERENA2 shows next-gen SERD camizestrant significantly reduces disease progression in advanced ER+ HER2- #BreastCancer.

👩🏻‍⚕️ Study led by Mafalda Oliveira of VHIO’s Breast Cancer Group.

linke.to/IISERENAVHIO...

First results from the VHIO-led FUSOMAP project (by Paolo Nuciforo & Elena Élez as co-author) identify intratumoral Fusobacterium as a potential biomarker in resectable colorectal cancer.
#FundaciónMutuaMadrileña, @isciiisalud.bsky.social & @cancerresearchuk.org
➡️ https://linke.to/FUSOMAPVHIO

🔬 #ASCO26 | New data from #ZZFIRST and #TALAPRO3 strengthen precision medicine in metastatic prostate cancer.
Led by Joaquin Mateo, the #VHIO Prostate Cancer Group played a key role in both studies. 

➡️ https://linke.to/JMateoASCO26
@ascocancer.bsky.social @nejm.org

VHIO at #ASCO25 ‼️

We played a prominent role — led a plenary study, contributed to 30+ oral communications, moderated sessions, and took part in 50+ scientific posters at the @ascocancer.bsky.social  annual meeting in Chicago.

#CancerResearch #Oncology

At @natmed.nature.com: VHIO-led study by José Antonio Seoane, first authored by Silvana Maas, links epigenetic changes caused by diet, tobacco, and pesticide exposure to early-onset colorectal cancer (under 50 years of age)
➡️ https://linke.to/NatureMedSeoane
#AECCVHIO @caixaresearch.bsky.socialprofile/did:plc:ejdmxeey6htqum7q2dtwhs2d" class="hover:underline text-blue-600 dark:text-sky-400 no-card-link" target="_blank" rel="noopener" data-link="bsky-mention">@caixaresearch.bsky.social

Epigenetic analysis has identified a link between exposure to the herbicide picloram and early-onset colorectal cancer, highlighting the impact of environmental factors on cancer risk. doi.org/hbx2w5

🎯 New research led by David G. Molleví (IDIBELL) & Dr. Artur Mezheyeuski (University of Uppsala and VHIO) sheds light on colorectal cancer liver metastases and their response to immunotherapy.

linke.to/IDIBELLVHIO

#VHIO_CRC #immunotherapy #PrecisionMedicine

🔴 #VallHebron shows long-term safety of CAR-T therapy in aggressive lymphoma patients.

🗞️ Published in #JAMANetwork, the study was led by @vhir.bsky.social, @vallhebroncampus.bsky.social  and #VHIO. 

👉 https://linke.to/CARTLymphomaVHIO

💙 Thank you, Padel Movember‼️

Your donation will support the project led by Nicolás Anselmino, from the Prostate Cancer Group at VHIO, which aims to understand the mechanisms of resistance in #ProstateCancer treatment.

👉 https://linke.to/PadelMovember25VHIO_ENG

💙 Thank you, Endavant Chic@s, for your commitment to research!

The association has donated more than €17,000 to support a project at #VHIO led by Adrià López on genetic risk communication and hereditary cancer prevention.

➡️ https://linke.to/XecEndavant_Eng

#MamaVHIO

Thank you, Paseíco de la Mama‼️ For 15 years of commitment to breast cancer research at #VHIO.

This year, the funds raised will support the PORTRAIT-TNBC project, led by Mafalda Oliveira, Senior Researcher at #MamaVHIO.

➡️ https://linke.to/PaseicoMama25VHIO_Eng

@cerca.cat

medicalxpress.com/news/2025-05... #AI #artificialintelligence

Results from the RADIOLA study by #SOLTI and #VHIO, led by Isabel Pimentel, Judith Balmaña and Aleix Prat: the RAD51 test identifies metastatic gBRCA, HER2− #BreastCancer patients who are 7 times more likely to respond to olaparib.
➡️ https://linke.to/RADIOLAVHIO
#SABCS25 @hospitalclinic.bsky.social

i just saw this get posted

Results of a new study from 🇪🇸 @vhio.bsky.social demonstrate the potential of a novel, #CT-based #deeplearning-driven tool to enhance #livercancer diagnosis, treatment planning, and response evaluation.

Certain 🧬 gene alterations can serve as a prognostic and predictive #biomarker for #prostatecancer. Now, researchers led by 🇪🇸 @vhio.bsky.social confirm the feasibility of using #NGS on this marker for precise patient stratification and treatment selection.

RAD51 testing may enhance patient stratification in metastatic prostate cancer by complementing next-generation sequencing, aiding in treatment selection, especially when tissue availability is limited. doi.org/g834vw

🚨 New publication
Study led by @VHIO, with our collaboration alongside #REQUITE & #RADprecise, shows that integrating genetic markers improves prediction of skin toxicity in #BreastCancer patients treated with #radiotherapy.
www.thebreastonline.com/article/S096...